SmofKabiven special 1518 ml

SmofKabiven special 1518 ml is a medicine authorised by Swissmedic under authorisation number 66670. The authorisation holder is Fresenius Kabi (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 29 October 2018 and the authorisation is valid without a time limit. ATC code B05BA10 places the medicine in the group Blood substitutes and perfusion solutions.

  • Dispensing category B
  • Authorisation number 66670
  • ATC B05BA10
  • Synthetic medicines
Authorisation data
Authorisation number66670
NameSmofKabiven special 1518 ml
Full nameSmofKabiven special 1518 ml, Infusionsemulsion
Authorisation holderFresenius Kabi (Schweiz) AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeB05BA10
First authorisation29 October 2018
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1SmofKabiven special 1518 ml, InfusionsemulsionB29 October 2018
2SmofKabiven special 1012 ml, InfusionsemulsionB29 October 2018

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
14 x 1518mlB05BA1007.01.2.B
24 x 1012mlB05BA1007.01.2.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is SmofKabiven special 1518 ml authorised in Switzerland?

Yes. SmofKabiven special 1518 ml is authorised by Swissmedic under authorisation number 66670, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does SmofKabiven special 1518 ml have?

SmofKabiven special 1518 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of SmofKabiven special 1518 ml?

The authorisation holder is Fresenius Kabi (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com